Annual ROE
-31.55%
-19.47%-161.18%
December 1, 2023
Summary
- As of February 7, 2025, MYGN annual return on equity is -31.55%, with the most recent change of -19.47% (-161.18%) on December 1, 2023.
- During the last 3 years, MYGN annual ROE has fallen by -25.65% (-434.75%).
- MYGN annual ROE is now -202.74% below its all-time high of 30.71%, reached on June 30, 2010.
Performance
MYGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-15.68%
+5.28%+25.19%
September 1, 2024
Summary
- As of February 7, 2025, MYGN quarterly return on equity is -15.68%, with the most recent change of +5.28% (+25.19%) on September 1, 2024.
- Over the past year, MYGN quarterly ROE has increased by +15.21% (+49.24%).
- MYGN quarterly ROE is now -152.49% below its all-time high of 29.87%, reached on June 30, 2010.
Performance
MYGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MYGN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -161.2% | +49.2% |
| 3 y3 years | -434.8% | -30.7% |
| 5 y5 years | -7111.1% | -545.3% |
MYGN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -973.1% | at low | -1681.8% | +53.6% |
| 5 y | 5-year | -7111.1% | at low | -1681.8% | +53.6% |
| alltime | all time | -202.7% | at low | -152.5% | +53.6% |
Myriad Genetics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -15.68%(-25.2%) |
| Jun 2024 | - | -20.96%(-32.1%) |
| Mar 2024 | - | -30.89%(-8.0%) |
| Dec 2023 | -31.55%(+161.2%) | -33.56%(-0.8%) |
| Sep 2023 | - | -33.82%(+17.7%) |
| Jun 2023 | - | -28.73%(+78.2%) |
| Mar 2023 | - | -16.12%(+34.3%) |
| Dec 2022 | -12.08%(+310.9%) | -12.00%(+47.4%) |
| Sep 2022 | - | -8.14%(+337.6%) |
| Jun 2022 | - | -1.86%(+111.4%) |
| Mar 2022 | - | -0.88%(-70.1%) |
| Dec 2021 | -2.94%(-50.2%) | -2.94%(-22.6%) |
| Sep 2021 | - | -3.80%(-69.7%) |
| Jun 2021 | - | -12.55%(-47.1%) |
| Mar 2021 | - | -23.73%(+20.9%) |
| Dec 2020 | -5.90%(-70.3%) | - |
| Sep 2020 | - | -19.62%(+0.8%) |
| Jun 2020 | -19.88%(-4517.8%) | -19.46%(+38.8%) |
| Mar 2020 | - | -14.02%(+477.0%) |
| Dec 2019 | - | -2.43%(+72.3%) |
| Sep 2019 | - | -1.41%(-427.9%) |
| Jun 2019 | 0.45%(-97.1%) | 0.43%(-80.9%) |
| Mar 2019 | - | 2.25%(-11.4%) |
| Dec 2018 | - | 2.54%(-54.6%) |
| Sep 2018 | - | 5.59%(-62.5%) |
| Jun 2018 | 15.37%(+568.3%) | 14.91%(-0.4%) |
| Mar 2018 | - | 14.97%(-1.3%) |
| Dec 2017 | - | 15.16%(+20.1%) |
| Sep 2017 | - | 12.62%(+444.0%) |
| Jun 2017 | 2.30%(-86.2%) | 2.32%(-28.2%) |
| Mar 2017 | - | 3.23%(-55.4%) |
| Dec 2016 | - | 7.24%(-37.2%) |
| Sep 2016 | - | 11.53%(-28.3%) |
| Jun 2016 | 16.62%(+43.2%) | 16.09%(-5.0%) |
| Mar 2016 | - | 16.94%(+9.8%) |
| Dec 2015 | - | 15.43%(+12.0%) |
| Sep 2015 | - | 13.78%(+18.9%) |
| Jun 2015 | 11.61%(-52.3%) | 11.59%(-14.2%) |
| Mar 2015 | - | 13.51%(-13.7%) |
| Dec 2014 | - | 15.66%(-19.4%) |
| Sep 2014 | - | 19.42%(-22.0%) |
| Jun 2014 | 24.34%(+12.8%) | 24.91%(-7.1%) |
| Mar 2014 | - | 26.81%(-2.3%) |
| Dec 2013 | - | 27.45%(+7.6%) |
| Sep 2013 | - | 25.51%(+15.3%) |
| Jun 2013 | 21.58%(+15.7%) | 22.12%(+8.8%) |
| Mar 2013 | - | 20.34%(+5.1%) |
| Dec 2012 | - | 19.35%(+3.0%) |
| Sep 2012 | - | 18.79%(+2.2%) |
| Jun 2012 | 18.65%(+4.1%) | 18.38%(-0.9%) |
| Mar 2012 | - | 18.55%(-1.6%) |
| Dec 2011 | - | 18.85%(+2.3%) |
| Sep 2011 | - | 18.42%(+1.7%) |
| Jun 2011 | 17.91%(-41.7%) | 18.11%(-21.2%) |
| Mar 2011 | - | 22.99%(-4.2%) |
| Dec 2010 | - | 24.01%(-10.6%) |
| Sep 2010 | - | 26.87%(-10.0%) |
| Jun 2010 | 30.71% | 29.87%(+25.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | 23.81%(+4.9%) |
| Dec 2009 | - | 22.69%(+12.2%) |
| Sep 2009 | - | 20.22%(+16.7%) |
| Jun 2009 | 19.68%(+57.6%) | 17.33%(-35.4%) |
| Mar 2009 | - | 26.81%(+18.0%) |
| Dec 2008 | - | 22.72%(+25.9%) |
| Sep 2008 | - | 18.05%(+36.6%) |
| Jun 2008 | 12.49%(-205.4%) | 13.21%(-278.5%) |
| Mar 2008 | - | -7.40%(-11.3%) |
| Dec 2007 | - | -8.34%(-18.2%) |
| Sep 2007 | - | -10.20%(-18.0%) |
| Jun 2007 | -11.85%(-40.2%) | -12.44%(-14.8%) |
| Mar 2007 | - | -14.60%(-14.0%) |
| Dec 2006 | - | -16.97%(-6.8%) |
| Sep 2006 | - | -18.21%(-1.6%) |
| Jun 2006 | -19.82%(-23.4%) | -18.51%(-6.7%) |
| Mar 2006 | - | -19.83%(-12.1%) |
| Dec 2005 | - | -22.56%(-16.6%) |
| Sep 2005 | - | -27.05%(+4.3%) |
| Jun 2005 | -25.88%(+7.3%) | -25.94%(-1.5%) |
| Mar 2005 | - | -26.34%(-1.7%) |
| Dec 2004 | - | -26.80%(+0.4%) |
| Sep 2004 | - | -26.69%(+0.9%) |
| Jun 2004 | -24.12%(+42.0%) | -26.44%(+8.6%) |
| Mar 2004 | - | -24.34%(+22.4%) |
| Dec 2003 | - | -19.88%(+7.4%) |
| Sep 2003 | - | -18.51%(+13.6%) |
| Jun 2003 | -16.98%(+63.0%) | -16.29%(-2.9%) |
| Mar 2003 | - | -16.77%(+4.4%) |
| Dec 2002 | - | -16.07%(+18.1%) |
| Sep 2002 | - | -13.61%(+32.5%) |
| Jun 2002 | -10.42%(+57.9%) | -10.27%(+52.1%) |
| Mar 2002 | - | -6.75%(+24.3%) |
| Dec 2001 | - | -5.43%(+13.4%) |
| Sep 2001 | - | -4.79%(-20.6%) |
| Jun 2001 | -6.60%(-52.3%) | -6.03%(-18.5%) |
| Mar 2001 | - | -7.40%(-20.3%) |
| Dec 2000 | - | -9.28%(-27.4%) |
| Sep 2000 | - | -12.78%(-16.1%) |
| Jun 2000 | -13.85%(-26.8%) | -15.23%(-6.7%) |
| Mar 2000 | - | -16.32%(-2.3%) |
| Dec 1999 | - | -16.71%(-10.5%) |
| Sep 1999 | - | -18.68%(-2.5%) |
| Jun 1999 | -18.92%(+19.4%) | -19.16%(-3.1%) |
| Mar 1999 | - | -19.77%(+0.8%) |
| Dec 1998 | - | -19.61%(+10.0%) |
| Sep 1998 | - | -17.82%(+13.2%) |
| Jun 1998 | -15.84%(+17.4%) | -15.74%(+55.1%) |
| Mar 1998 | - | -10.15%(-7.4%) |
| Dec 1997 | - | -10.96%(-13.4%) |
| Sep 1997 | - | -12.65%(-9.3%) |
| Jun 1997 | -13.49%(+60.6%) | -13.95%(-17.9%) |
| Mar 1997 | - | -16.99%(+18.0%) |
| Dec 1996 | - | -14.40%(+41.5%) |
| Sep 1996 | - | -10.18%(+21.8%) |
| Jun 1996 | -8.40% | -8.36%(+48.0%) |
| Mar 1996 | - | -5.65%(+80.5%) |
| Dec 1995 | - | -3.13% |
FAQ
- What is Myriad Genetics annual return on equity?
- What is the all time high annual ROE for Myriad Genetics?
- What is Myriad Genetics annual ROE year-on-year change?
- What is Myriad Genetics quarterly return on equity?
- What is the all time high quarterly ROE for Myriad Genetics?
- What is Myriad Genetics quarterly ROE year-on-year change?
What is Myriad Genetics annual return on equity?
The current annual ROE of MYGN is -31.55%
What is the all time high annual ROE for Myriad Genetics?
Myriad Genetics all-time high annual return on equity is 30.71%
What is Myriad Genetics annual ROE year-on-year change?
Over the past year, MYGN annual return on equity has changed by -19.47% (-161.18%)
What is Myriad Genetics quarterly return on equity?
The current quarterly ROE of MYGN is -15.68%
What is the all time high quarterly ROE for Myriad Genetics?
Myriad Genetics all-time high quarterly return on equity is 29.87%
What is Myriad Genetics quarterly ROE year-on-year change?
Over the past year, MYGN quarterly return on equity has changed by +15.21% (+49.24%)